Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Overview of attention for article published in Frontiers in Pharmacology, October 2018

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter: 4 X users

patent: 2 patents

Citations

dimensions_citation: 144 Dimensions

Readers on

mendeley: 121 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

MODIFIED IMMUNE CELL TARGETING HEPATITIS B SURFACE ANTIGEN AND MEDICAL USE THEREOF

Application WO-2024049348-A1

World Intellectual Property Organisation (WIPO)

METHOD FOR PRODUCING NK CELLS WITH PD-1 KNOCKOUT GENE AND TRAIL OR FAS-LIGAND…

Application EP-3954775-A4

European Patent Office

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.